Publication | Closed Access

The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson’s disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram

Neurobiology Of DiseasePsychiatryPsychotropic MedicationParkinson DiseaseAnimal ModelPsychopharmacologyNeuropharmacologySocial SciencesNeuroscienceNeurologyDopamineMedicineLevodopa-induced DyskinesiasMovement DisordersChronic Treatment